Team Building Activities


Danatlas Pharmaceuticals Wins the "Deloitte China Healthcare Seed Award"


On December 16, 2025, the highly anticipated "Deloitte China Top 50 High-Tech Growth Companies and Rising Stars & Seed Awards Ceremony," which has drawn global attention in the science and innovation sector, was solemnly held in Wuxi. Beijing Danatlas Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Danatlas") stood out from numerous candidate companies thanks to its groundbreaking technological innovations in the field of precision targeted cancer therapy, strong R&D capabilities, and promising market prospects. As a result, Danatlas successfully won the "Deloitte China Pharma & Healthcare Seed Award," becoming one of the benchmark enterprises with the greatest growth potential in the pharmaceutical and healthcare sector.

2025-12-17

Breakthrough again! Danqing Pharmaceutical's POLQ inhibitor IND has been approved for both China and the United States


Breakthrough again! Danqing Pharmaceutical's POLQ inhibitor IND has been approved for both China and the United States

2025-06-23

Beijing Danatlas Technology

Tel: 010-67803200

Website: www.danatlas.com

Email: info@danatlas.com

Address: Building 4A, District 2, Yizhuang International Biomedical Park, No. 7 Liangshuihe 1st Street, Beijing Economic and Technological Development Zone, Beijing

Copyright @ 2019-2022 Beijing Danatlas Pharmaceutical Technology Co., Ltd. All rights reserved.  TAG

business licence